EuropaBio and Novartis invite to explore a pathway for green transition in the biopharmaceutical ecosystem

Brussels, 13 October 2021  At the time of the 25th Anniversary of EuropaBio, we would like to look to the future and the green transition that will shape healthcare for us all. EuropaBio and Anniversary sponsor Novartis are inviting to the open webinar ‘‘Healthy planet, Healthy people” which will take place on the 25th of October… Continue reading EuropaBio and Novartis invite to explore a pathway for green transition in the biopharmaceutical ecosystem

EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years

Brussels, 5 July 2021 From micro-organism production of the world’s vitamin B2, a revolution in cancer therapy using our own immune systems, and the first Covid mRNA vaccine approved – these are just a few examples of the selected landmarks in biotechnology that were officially announced today as the start of EuropaBio’s 25th Anniversary programme.… Continue reading EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years

Novartis is proud to support the EuropaBio 25th Anniversary

Brussels, Belgium – 14 June 2021 – EuropaBio today announced that Novartis, the Swiss pharma company, has joined EuropaBio’s 25th Anniversary Celebration Programme as a sponsor. Novartis, which itself celebrates 25 years since its creation through the merger of Ciba-Geigy and Sandoz in 1996, has the purpose of remaining medicine to improve and extend people’s… Continue reading Novartis is proud to support the EuropaBio 25th Anniversary

Interview with… Cyrille Pauthenier, CEO of Abolis

EuropaBio sat down with new member (and Anniversary sponsor) Abolis, to find out about their journey from creation in 2014. 1) What inspired the foundation of Abolis? Abolis Biotechnologies is inspired by a strong conviction.I was an enthusiast student in chemistry when I first came to the lab and made an organic chemistry synthesis with… Continue reading Interview with… Cyrille Pauthenier, CEO of Abolis

Abolis joins the EuropaBio 25th Anniversary in 2021

Brussels, Belgium – March 29, 2021 – EuropaBio today announced that Abolis, a fast-growing French biotech company specialized in enabling the biosynthesis of sustainable molecules for food & feed, cosmetics, flavours & fragrances, specialty chemicals and pharmaceuticals via advanced microbial strain engineering, has joined EuropaBio’s 25th Anniversary Celebration Programme as a sponsor. With a mission… Continue reading Abolis joins the EuropaBio 25th Anniversary in 2021

Catalent joins the EuropaBio 25th Anniversary in 2021

Brussels, Belgium – March 9, 2021 – EuropaBio today announced that Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, has joined EuropaBio’s 25th Anniversary Celebration Programme as a major sponsor. With a mission to celebrate the most significant scientific… Continue reading Catalent joins the EuropaBio 25th Anniversary in 2021

EuropaBio celebrates 25 years of biotech innovation with 2021 Anniversary Programme

Brussels, Belgium – April 5, 2021, EuropaBio, Europe’s leading life sciences industry association, kicks off 2021 celebrations to mark its foundation a quarter of a century ago. The anniversary has the mission to celebrate the most significant scientific and commercial advances in European biotechnology for each of the last 25 years. During the year, EuropaBio,… Continue reading EuropaBio celebrates 25 years of biotech innovation with 2021 Anniversary Programme